Furthermore, the relationship between RPL35A expression and clinicopathologic features in ovarian cancer patients, such as age, grade, stage, tumour size, T Infiltrate (T), lymphatic metastasis (N), metastasis (M) and recurrence, was analysed using the Mann–Whitney U test (Table 2). This evidence concerns the gene RPL35A and ovarian carcinoma.